UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056030
Receipt number R000064030
Scientific Title Alleviating effect of dairy ingredients on dry feeling : A randomized, double-blind, placebo-controlled, crossover study.
Date of disclosure of the study information 2024/11/04
Last modified on 2024/11/03 12:18:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Alleviating effect of dairy ingredients on dry feeling : A randomized, double-blind, placebo-controlled, crossover study.

Acronym

Alleviating effect of dairy ingredients on dry feeling.

Scientific Title

Alleviating effect of dairy ingredients on dry feeling : A randomized, double-blind, placebo-controlled, crossover study.

Scientific Title:Acronym

Alleviating effect of dairy ingredients on dry feeling.

Region

Japan


Condition

Condition

None (Healthy subjects)

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of a dairy ingredient on dry feeling.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Dry feeling

Key secondary outcomes

Saliva-related indexes


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

A single intake of dairy ingredient.

Interventions/Control_2

A single intake of placebo.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Subjects who aged 18 years or older and younger than 60 years.

Key exclusion criteria

1) Subjects whose salivary flow rate are less than 0.1mL/min.
2) Subjects who have diseases of tooth, mouth, pharynx, larynx, esophagus and respiratory apparatus.
3) Subjects who cannot stop taking functional foods or using oral care products, that influence oral environment.
4) Subjects who put a burden on their mouth, pharynx, larynx, esophagus and respiratory apparatus.
5) Smoker.
6) Extremely heavy drinkers (more than 60g/day of alcohol).
7) Subjects whose lifestyle habits are irregular.
8) Subjects who have serious disease in the liver, kidney, heart, lung, gastrointestinal tract, blood, endocrine system, metabolic system, or have chronic disease etc. Or those who have serious medical history of these.
9) Subjects having a serious food allergy such as milk allergy, or drug allergy. Or those who have serious medical history of these.
10) Subjects who are pregnant or under lactation, or who is expected to be pregnant during the study.
11) Others who have been determined as ineligible for the research subject of this study, judging from the principal researcher/doctor's opinions on the findings of their background etc.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Miyuki
Middle name
Last name Tanaka

Organization

Morinaga Milk Industry Co., Ltd.

Division name

Innovative Research Institute, R&D Division

Zip code

252-8583

Address

5-1-83, Higashihara, Zama city, Kanagawa, Japan

TEL

046-252-3070

Email

m_tanaka@morinagamilk.co.jp


Public contact

Name of contact person

1st name Naoko
Middle name
Last name Imai

Organization

SOUKEN Co., Ltd.

Division name

Secretariat

Zip code

105-0013

Address

3F Daiwa A Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo

TEL

03-5408-1555

Homepage URL


Email

jimukyoku@mail.souken-r.com


Sponsor or person

Institute

Morinaga Milk Industry Co., Ltd., Innovative Research Institute, R&D Division

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Committee

Address

6F Daiwa A Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo

Tel

03-5408-1599

Email

jimukyoku@mail.souken-r.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 09 Month 27 Day

Date of IRB

2024 Year 09 Month 27 Day

Anticipated trial start date

2024 Year 11 Month 05 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 11 Month 03 Day

Last modified on

2024 Year 11 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064030